Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 12Unknown 4Terminated 2Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 8Gynecologic 4Lymphoid 1Genitourinary 1

Conditions

Uterine Cervical Dysplasia 4

Interventions

Paclitaxel 79Cisplatin 72Carboplatin 72Bevacizumab 29Radiotherapy 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 19Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 15liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Taxes 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Injections 7Cytoreduction Surgical Procedures 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Imiquimod × Gynecologic × Clear all
NCT04859361 2021-05-03

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

University Medical Centre Maribor

Phase NA Unknown
104 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT02917746 2018-08-16

TOPIC-3

Maastricht University Medical Center

Phase NA Unknown
120 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT02669459 2018-02-06

TopIC-2

Erasmus Medical Center

Phase 3 Unknown
433 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT03206138 2017-07-02

Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.

Seoul St. Mary's Hospital

Phase NA Unknown
50 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡